Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01129791 · ClinicalTrials.gov registry record · NA
Effects of Raw Versus Other Milk Sources on Lactose Digestion
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01129791: Completed NA study, sponsored by Stanford University.
NCT01129791 is a NA study that has completed, run by Stanford University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01129791, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of different types of milk (raw milk, cow's milk, nondairy-milk) on lactose maldigestion.
Primary Outcome
Calculated as the H2 AUC above baseline at day 8 minus the H2 AUC above baseline at day 1 of each milk phase
Interventions
- BEHAVIORAL Raw Milk
- BEHAVIORAL Pasteurized Milk
- BEHAVIORAL Non-dairy milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT01129791 record still lists
NCT01129791 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Raw Milk is the first listed.
NCT01129791 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01129791 about?
NCT01129791 is a clinical study titled "Effects of Raw Versus Other Milk Sources on Lactose Digestion". The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of different types of milk (raw milk, cow's milk, nondairy-milk) on lactose maldigestion.
What is the current status of trial NCT01129791?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2010-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01129791?
The interventions under investigation include: Raw Milk (BEHAVIORAL), Pasteurized Milk (BEHAVIORAL), Non-dairy milk (BEHAVIORAL).
Who is sponsoring clinical trial NCT01129791?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01129791's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia